Victor Grifols, CEO, Instituto Grifols, Spain
”Grifols: from the family to the company - Contributions to Hemotherapy.”
Jan Over, Sanquin Plasma Products, The Netherlands
”Impact of Technology Transitions in the Plasma Business.”
Jeffrey Ravetch, Rockefeller University, U.S.A.
”Novel roles for IgG glycans.”